Biopharma IPOs In 2016: Fewer Offerings, Better Returns As Firms Adjust To Market Realities

The number of US biopharma IPOs during the first 11 months of 2016 – 29 companies went public – is less than half of the 2015 total of 62, but stock performance has improved as investors focus on quality.